Autologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep model

International journal of nanomedicine

Volumn 9, Issue , 2014, Pages 5317-5339

  Boos, Anja M ^a   Weigand, Annika ^a   Deschler, Gloria ^a   Gerber, Thomas ^a   Arkudas, Andreas ^a   Kneser, Ulrich ^a   Horch, Raymund E ^a   Beier, Justus P ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

autologous serum; bone tissue engineering; mesenchymal stem cells; nanostructured bone substitute; recombinant human bone morphogenetic protein 2; sheep model

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE PROSTHESIS; DRUG CARRIER; NANOCOMPOSITE; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; SILICON DIOXIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; APOPTOSIS; BONE DEVELOPMENT; BONE PROSTHESIS; CHEMISTRY; DRUG EFFECTS; FEMALE; HUMAN; MESENCHYMAL STROMA CELL; PHARMACOLOGY; PHYSIOLOGY; SERUM; SHEEP; TISSUE ENGINEERING;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 2; BONE SUBSTITUTES; DRUG CARRIERS; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; NANOCOMPOSITES; OSTEOGENESIS; RECOMBINANT PROTEINS; SERUM; SHEEP; SILICON DIOXIDE; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 84929476028     PISSN: None     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S66867     Document Type: Article

References (0)